On Friday, TiVo Inc. (NASDAQ:TIVO)’s shares declined -1.68% to $10.56.
TiVo Inc. ( TIVO), a leader in the advanced television entertainment market, recently declared that President and CEO Tom Rogers will present at the NASDAQ OMX International Investor Program on Tuesday, June 30th. A webcast of the presentation will be accessible on the Investor Relations section of the TiVo website at http://investor.tivo.com under the events calendar tab.
TiVo Inc. provides television software services and cloud-based software-as-a-service solutions that enable to view video content through various screens. It offers whole-home solutions that comprise 4-Tuner and 6-Tuner digital video recorders (DVRs)/gateways, non-DVR IP set-top boxes (STBs), and software to enable streaming to application on third-party devices, such as iOS and Android mobile phones and tablets through features, such as What to Watch Now, OnePass, integrated search, access to broadband video content, and TiVo online/mobile scheduling.
Pernix Therapeutics Holdings Inc (NASDAQ:PTX)’s shares gained 5.99% to $5.66.
Bellamy Young, actress and singer, best known for her role as First Lady ‘Mellie’ Grant on ABC’s drama “Scandal”, has partnered with Pernix Therapeutics (PTX), the makers of TREXIMET®, to share her experience with migraines in conjunction with National Migraine Awareness Month. As one of the more than 36 million Americans1 who suffer from migraines, Bellamy hopes to drive national awareness of the impact migraines can have, particularly in the summer when warmer weather and shifts in daily routines may trigger symptoms.
As Bellamy is well aware, the unpredictable, intense pain of migraines often impacts sufferers’ personal and professional lives in a meaningful way. In fact, a new survey conducted by Everyday Health, Inc., on behalf of Pernix Therapeutics revealed that 8 in 10 female migraine sufferers2 said having migraines makes them feel less in control of their lives, while half agreed their personal relationships suffer because of their migraines.
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products. The company’s product comprise CEDAX, an oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; Zutripro, Rezira, and Vituz for the relief of cough and nasal congestion; and OMECLAMOX-PAK a gastroenterology product.
At the end of Friday’s trade, Amazon.com, Inc. (NASDAQ:AMZN)‘s shares dipped -0.45% to $438.10.
Amazon declared a new Kindle sharing experience that makes it simple for people to have conversations about great books—using the mobile messaging apps they already love, and even with people who have never used Kindle before. Kindle readers could already share quotes and recommendations with all their friends on Facebook or Twitter, and now they can start a conversation with specific people. And clicking on a book recommendation or shared quote now lets people start reading instantly, much like typical links to articles and videos. Here’s how it works:
- From a Kindle book, easily share quotes, highlights, and recommendations with specific friends.
- Share via popular mobile messaging apps like Facebook Messenger and WhatsApp, in addition to email, texting, and more.
- Share recently from Kindle for Android, and coming to Kindle e-readers and other devices later this year.
- Friends who receive a share can instantly start reading a free book preview right from their phone, tablet, or PC—no need to sign up, sign in, or install an app.
Amazon.com, Inc. operates as an online retailer in North America and internationally. It operates in two segments, North America and International. The company serves consumers through retail Websites, such as amazon.com and amazon.ca, which primarily comprise merchandise and content purchased for resale from vendors and those offered by third-party sellers. It also offers programs that enable sellers to sell their products on company’s Websites, and their own branded Websites; and programs, which allow authors, musicians, filmmakers, app developers, and others to publish and sell content.
VCA Inc (NASDAQ:WOOF), ended its Friday’s trading session with 0.26% gain, and closed at $54.87.
VCA Inc. (WOOF) VCA Inc., a leading provider of pet health care services in the country, is among a distinguished group of organizations honored for their innovation and talent administration excellence by Cornerstone OnDemand. At Cornerstone’s 13th annual client conference, VCA received the RAVE award in the category of Advancement in Reinventing Work for the development of the VCA Employee Success Center.
The center comprises WOOF University, which provides career development and training for more than 17,000 VCA employees; VetFlix, a WOOF U feature that provides interactive virtual classrooms for medical and administration topics; and PURRformance, that provides employee performance feedback tied to WOOF U development opportunities.
The five winners were selected from among 2,200 Cornerstone clients that encompass multi-national corporations, large domestic enterprises, mid-market companies, public sector organizations, education institutions and non-profit entities. Winners were evaluated across a wide range of criteria and recognized based on their innovative approaches to using and adopting Cornerstone’s software and services.
VCA Inc. operates as an animal healthcare company in the United States and Canada. It operates through two segments, Animal Hospital and Laboratory. The Animal Hospital segment offers general medical and surgical services, in addition to specialized treatments comprising advanced diagnostic services, internal medicine, oncology, neurology, endocrinology, ophthalmology, dermatology, and cardiology for companion animals; and sells related retail and pharmaceutical products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
